Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

July 23, 2021, 10:03 a.m. EDT

Moderna's stock jumps after announcing its COVID-19 shot is nearing authorization for teens in Europe

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -3.80% gained 4.7% in trading on Friday after the company said that European regulators recommended authorizing its COVID-19 vaccine for teens as young as 12 years old. The European Medicines Agency's Committee for Medicinal Products for Human Use issued the recommendation; next up will be the final decision from the European Commission. Moderna's shot has not yet been authorized for teens in the U.S. The company's shares have soared 223.2% so far this year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.16% is up 16.3%.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 437.34
-17.26 -3.80%
Volume: 4.91M
Sept. 24, 2021 11:31a
P/E Ratio
54.70
Dividend Yield
N/A
Market Cap
$183.50 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,441.97
-7.01 -0.16%
Volume: 619.78M
Sept. 24, 2021 11:32a
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.